CLINICAL_TRIALS
research
· 2018-04-17
Clinical Trial Update: Study to Investigate the Effect of an Oral Diamine Oxidase Substitution (DAOsin) in Histamine Intolerant Patients on the Low Endogenous Diamine Oxidase Serum Activity [NA]
Summary
A clinical trial evaluating an oral diamine oxidase substitute (DAOsin) in histamine-intolerant patients has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sciotec Diagnostic Technologies GmbH | Conditions: Food Intolerance, Histamine Intolerance | NA | Status: COMPLETED